Delayed alloimmunization using random single donor platelet transfusions: a prospective study in thrombocytopenic patients with acute leukemia
J Gmür, A. von Felten, Bruno Osterwalder et al. · Blood · 1983
A randomized study was performed in 54 thrombocytopenic patients with acute leukemia. Alloimmunization of recipients of random multiple-donor platelet concentrates (MD group) was compared to that of patients receiving random single-donor platelets (SD group). In the SD patients, formation of alloantibodies (mostly anti-HLA) occurred less frequently (p less than 0.002), after a longer time period (p less than 0.002), and after a higher number of transfusions (p less than 0.005) as compared to MD patients. SD patients also became refractory to random platelets less frequently (p less than 0.005), after a longer time period, and after a higher number of transfusions (p less than 0.02). In SD patients, the increments after the first and the last transfusion were in the same range, whereas in MD patients, the 1-hr (p less than 0.001) and the 24-hr (p less than 0.025) increments decreased from the first to the last transfusion. Thus, the use of random SD platelet transfusions postponed alloimmunization.
Cited by 144 works. doi:10.1182/blood.v62.2.473.473 Open-access PDF
Authors
- J Gmür
- A. von Felten
- Bruno Osterwalder
- Hanspeter Honegger
- A. Hörmann
- K A Deubelbeiss
- Willi Berchtold
- M. N. Metaxas
- Giancarlo Scali
- Frick Pg
References
- Nonparametric Estimation from Incomplete Observations
- Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.
- SEROTYPING FOR HOMOTRANSPLANTATION XVIII. REFINEMENT OF MICRODROPLET LYMPHOCYTE CYTOTOXICITY TEST
- Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia.
- Platelet Transfusion Therapy
- Alloimmunization following platelet transfusion: the absence of a dose- response relationship
- The Natural History of Alloimmunization to Platelets
- Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations
- Antibody response in patients with acute nonlymphocytic leukemia
- Matching of histocompatibility (HL-A) antigens for platelet transfusion